Androski Lindsay (CIK 1936604) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-23). Recent activity: Buy ABUS (116,408 shares), Buy ABUS (10,456 shares), Sell ABUS (82,527 shares), Buy ABUS (28,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | Arbutus Biopharma Corp (ABUS) | President and CEO | Buy | 116,408 | $372,506 |
| 2026-09-23 | Arbutus Biopharma Corp (ABUS) | President and CEO | Buy | 10,456 | $45,902 |
| 2026-09-23 | Arbutus Biopharma Corp (ABUS) | President and CEO | Sell | 82,527 | $418,412 |
| 2026-02-02 | Arbutus Biopharma Corp (ABUS) | President and CEO | Buy | 28,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-23